MedPath

Birkebeiner II Study

Completed
Conditions
Atrial Fibrillation
Registration Number
NCT03741491
Lead Sponsor
Diakonhjemmet Hospital
Brief Summary

Prolonged endurance exercise is associated with an elevated risk of atrial fibrillation (AF). The mechanisms governing this increased risk remains elusive. This study aim to detail the specific traits of elderly subjects with AF conducting endurance training by comparing elderly participators in the Birkebeiner cross country ski race(an indicator of prolonged endurance exercise practice) with and without AF to a not-so-trained control group.

Detailed Description

In recent years endurance sports with high intensity and participation in competition have been increasingly popular among middle aged and older people. The Birkebeiner studies are investigations of elderly non-professional athletes (65 years or older at enrollment in 2009/10) participating in the Birkebeiner cross-country ski race. It consists of Birkebeiner Aging Study, BIAS and the Birkebeiner Atrial Fibrillation, (BAF-study). The BAF-study investigated the association between prolonged endurance sport practice and the risk of AF by comparing the cohort of veteran cross-country skiers to a control population drawn from the Health and Environment Study in Oslo (HELMILO 2009).

The main findings of the Birkebeiner study so far have been that participation in the Birkebeiner cross-country ski race (an indicator of prolonged endurance exercise practice) is associated with an elevated risk of atrial fibrillation (AF) among men ≥ 65 years, and that this risk correlates with the cumulated amount of endurance-training. Similar findings were seen amongst female athletes. This increased risk of AF was shown independent of other known significant comorbidities (such as hypertension and diabetes), indicating that endurance-training at this level itself is an independent risk factor.

Regular physical exercise is an important factor when it comes to successful ageing. However, dose-relationship of physical exercise in a longer perspective is poorly studied. Atrial fibrillation is associated with increased risk of stroke, heart failure, dementia and death.

The mechanisms governing the increased risk of AF in elderly subjects undergoing endurance-training remains elusive. This study aim to detail the specific traits of elderly subjects with AF conducting endurance-training in comparison with trained and not-so-trained control groups. Thus, generating knowledge that can form the basis for better prevention and treatment of AF in this group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
395
Inclusion Criteria
  • Already included in the Birkebeiner studies or "Health and environment study in Oslo" (HELMILO)
  • Born 1960 and earlier
Exclusion Criteria
  • Born before 1935.
  • Earlier heart valve surgery.
  • MI (Mitral Insufficiency)≥ grade 3
  • Ejection Fraction (EF) <35%

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in atrial function and presence of atrial fibrillation in veteran endurance athletesCross sectional study. Measured at time for inclusion.

2D strain (%) in the three phases of atrial function, measured by triplane echocardiography.

Secondary Outcome Measures
NameTimeMethod
Changes in R-R variability (msec) in veteran endurance athletesCross sectional study. Measured at time for inclusion.

Measured by Holter ECG recordings

Presence of 171 genetic variants known to be associated with atrial fibrillation in veteran endurance athletes.Cross sectional study. Measured at time for inclusion.

Measured by genome-wide genotyping and next generation sequencing in the combination with Sanger sequencing.

European Heart Rhythm Association (EHRA) score of atrial fibrillation related symptoms in veteran endurance athletes.Cross sectional study. Measured at time for inclusion.

Measured by European Heart Rhythm Association symptom score which is a classification of AF-related symptoms. The score ranges from I-no symptoms to IV-disabling symptoms.

Changes in right ventricular volumes (ml) in veteran endurance athletesCross sectional study. Measured at time for inclusion.

Measured by 2D echocardiography

Changes in p-wave (p-wave duration (msec), morphology and axis) in veteran endurance athletesCross sectional study. Measured at time for inclusion.

Measured by ECG derived vector cardiograms.

Changes in biochemical markers associated with atrial fibrosis and inflammation in veteran endurance athletes.Cross sectional study. Measured at time for inclusion.

IL-1alfa, -1ra, -4,-6,-10, -17A, -17F, -21, -22, -23, -25, -31, -33, IFN-gamma TNF-alfa, IP-10, G-CSF, GM-CSF, MCP-1, MIP-1alfa, MIP-1beta, TIMP-1-4, MMP 1-3,7-10 and 12, measured by luminex multiplex technology

Trial Locations

Locations (1)

Diakonhjemmet Hospital

🇳🇴

Oslo, Norway

© Copyright 2025. All Rights Reserved by MedPath